Effectiveness and safety of follitropin delta in routine clinical practice in the Nordics and Switzerland (the NORSOS study): a prospective non-interventional study

BackgroundFollitropin delta is the first approved human recombinant follicle-stimulating hormone treatment administered through an algorithmic individualized dosing regimen based on body weight and anti-Müllerian hormone (AMH) levels. This study assesses the effectiveness and safety profile of folli...

Descripción completa

Detalles Bibliográficos

Autores principales:	Anja Pinborg, Negjyp Sopa, Erling Ekerhovd, Stavros I. Iliadis, June Kaspersen, Enrica Gravotta, Alexander Quaas
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2025-09-01
Colección:	Frontiers in Endocrinology
Materias:	follitropin delta in vitro fertilization assisted reproductive technology anti-Müllerian hormone pregnancy ovarian stimulation
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1613680/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!